Theravance Biopharma reports Q2 2026 results, confirms Zymeworks deal on track for second half closeAug 10Quarterly updateTheravance Biopharma
Zymeworks flags August 25 PDUFA date for zanidatamab, updates pipeline and Theravance timelineAug 6Quarterly updateJazz Pharmaceuticalszanidatamab-hrii
Viatris-collaborated trial registered comparing Yupelri/Perforomist combo to standard COPD therapyJul 23Trial updateformoterolrevefenacin
Sign inSign in